𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Striatal calcium channel antagonist receptors in huntington's disease and parkinson's disease

✍ Scribed by Daniel L. Watson; Celia L. Carpenter; Shelley S. Marks; Dr. David A. Greenberg

Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
348 KB
Volume
23
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Selegiline and mortality in Parkinson's
Selegiline and mortality in Parkinson's disease
✍ Dr. C. W. Olanow; S. Fahn; J. W. Langston; J. Godbold πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 489 KB πŸ‘ 2 views

## Do Other Studies Show Increased Mortality Due to Selegiline? Other than the UK study, no clinical trial to date has shown an increase in mortality in association with the use of selegiline. In the Sindepar study, a cohort of I01 untreated P D patients participated in a 14-month prospective, ran